Bayer to Buy Conceptus in $1.1B Birth Control Deal

by Christopher Freeburn | April 29, 2013 11:29 am

49266_S15[1]Shares of Conceptus (NASDAQ:CPTS[2]) surged almost 20% in Monday morning trading after Bayer AG (PINK:BAYRY[3]) said it would buy the birth control products maker[4].

The German pharmaceutical giant is offering $31 a share for Conceptus, valuing the acquisition at $1.1 billion, the Associated Press noted.

Not surprisingly, Conceptus shares jumped to just under $31 a share. The California-based company produces a permanent contraceptive treatment under the brand name Essure. The treatment uses metal and polyester bands to constrict a woman’s fallopian tubes, preventing pregnancy.

Regulators will have to approve the deal.

The purchase would add to Bayer’s existing range of contraceptive products. Conceptus has a workforce of roughly 300. The companies expect to finalize the merger later this year.

In November, Bayer acquired Utah-based vitamin producer Schiff Nutrition International[5] for $1.1 billion.

Shares of Bayer rose fractionally in over-the-counter trading on Monday.

  1. [Image]:
  2. CPTS:
  3. BAYRY:
  4. buy the birth control products maker:
  5. acquired Utah-based vitamin producer Schiff Nutrition International:

Source URL:
Short URL: